ALP 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
3 6 7 6 7 B-lower_bound
x 8 9 8 9 I-lower_bound
ULN 10 13 10 13 I-lower_bound

ALT 0 3 14 17 B-clinical_variable
> 4 5 18 19 O
3 5 6 19 20 B-lower_bound
x 7 8 21 22 I-lower_bound
ULN 9 12 23 26 I-lower_bound

ALT 0 3 27 30 B-clinical_variable
> 4 5 31 32 O
5 5 6 32 33 B-lower_bound
x 7 8 34 35 I-lower_bound
ULN 9 12 36 39 I-lower_bound

AST 0 3 40 43 B-clinical_variable
> 4 5 44 45 O
3 5 6 45 46 B-lower_bound
x 7 8 47 48 I-lower_bound
ULN 9 12 49 52 I-lower_bound

AST 0 3 53 56 B-clinical_variable
> 4 5 57 58 O
5 5 6 58 59 B-lower_bound
x 7 8 60 61 I-lower_bound
ULN 9 12 62 65 I-lower_bound

Calculated 0 10 66 76 B-clinical_variable
Creatinine 11 21 77 87 I-clinical_variable
Clearance 22 31 88 97 I-clinical_variable
< 32 33 98 99 O
50 34 36 100 102 B-upper_bound
mL 37 39 103 105 I-upper_bound
( 40 41 106 107 O
as 41 43 107 109 O
calculated 44 54 110 120 O
by 55 57 121 123 O
Cockcroft 58 67 124 133 O
/ 67 68 133 134 O
Gault 68 73 134 139 O
) 73 74 139 140 O

Cardiac 0 7 141 148 O
( 8 9 149 150 O
left 9 13 150 154 O
heart 14 19 155 160 O
) 19 20 160 161 O
insufficiency 21 34 162 175 O
( 35 36 176 177 O
defined 36 43 177 184 O
as 44 46 185 187 O
LVEF 47 51 188 192 B-clinical_variable
< 52 53 193 194 O
35 53 55 194 196 B-upper_bound
% 55 56 196 197 I-upper_bound
) 56 57 197 198 O
at 58 60 199 201 O
screening 61 70 202 211 O

Chest 0 5 212 217 B-treatment
x 6 7 218 219 I-treatment
- 7 8 219 220 I-treatment
ray 8 11 220 223 I-treatment
within 12 18 224 230 O
the 19 22 231 234 O
last 23 27 235 239 B-upper_bound
six 28 31 240 243 I-upper_bound
( 32 33 244 245 I-upper_bound
6 33 34 245 246 I-upper_bound
) 34 35 246 247 I-upper_bound
months 36 42 248 254 I-upper_bound

Chronic 0 7 255 262 B-chronic_disease
microbial 8 17 263 272 I-chronic_disease
lung 18 22 273 277 I-chronic_disease
colonization 23 35 278 290 I-chronic_disease
( 36 37 291 292 O
≥6 37 39 292 294 O
months 40 46 295 301 I-lower_bound
) 46 47 301 302 O
with 48 52 303 307 O
presence 53 61 308 316 O
of 62 64 317 319 O
Pseudomonas 65 76 320 331 B-chronic_disease
aeruginosa 77 87 332 342 I-chronic_disease
, 87 88 342 343 O
Staphylococcus 89 103 344 358 B-chronic_disease
aureus 104 110 359 365 I-chronic_disease
or 111 113 366 368 O
Stenotrophomonas 114 130 369 385 B-chronic_disease
maltophilia 131 142 386 397 I-chronic_disease
in 143 145 398 400 O
at 146 148 401 403 O
least 149 154 404 409 O
two 155 158 410 413 B-lower_bound
( 159 160 414 415 O
2 160 161 415 416 O
) 161 162 416 417 O
sputum 163 169 418 424 O
cultures 170 178 425 433 O
in 179 181 434 436 O
the 182 185 437 440 O
past 186 190 441 445 O
year 191 195 446 450 O
( 196 197 451 452 O
the 197 200 452 455 O
screening 201 210 456 465 O
culture 211 218 466 473 O
can 219 222 474 477 O
count 223 228 478 483 O
as 229 231 484 486 O
one 232 235 487 490 O
of 236 238 491 493 O
the 239 242 494 497 O
two 243 246 498 501 O
positive 247 255 502 510 O
cultures 256 264 511 519 O
) 264 265 519 520 O

Clinically 0 10 521 531 O
stable 11 17 532 538 O
with 18 22 539 543 O
no 23 25 544 546 O
significant 26 37 547 558 O
changes 38 45 559 566 O
in 46 48 567 569 O
health 49 55 570 576 O
status 56 62 577 583 O
within 63 69 584 590 O
14 70 72 591 593 B-upper_bound
days 73 77 594 598 I-upper_bound
prior 78 83 599 604 I-upper_bound
to 84 86 605 607 O
Baseline 87 95 608 616 O

Confirmed 0 9 617 626 O
diagnosis 10 19 627 636 O
of 20 22 637 639 O
Cystic 23 29 640 646 B-chronic_disease
Fibrosis 30 38 647 655 I-chronic_disease

Current 0 7 656 663 O
use 8 11 664 667 O
of 12 14 668 670 O
inhaled 15 22 671 678 B-treatment
steroids 23 31 679 687 I-treatment
> 32 33 688 689 O
500 33 36 689 692 B-lower_bound
micrograms 37 47 693 703 I-lower_bound
twice 48 53 704 709 O
daily 54 59 710 715 O
of 60 62 716 718 O
Fluticasone 63 74 719 730 B-treatment
or 75 77 731 733 O
equivalent 78 88 734 744 O
in 89 91 745 747 O
the 92 95 748 751 O
30 96 98 752 754 B-upper_bound
days 99 103 755 759 I-upper_bound
prior 104 109 760 765 I-upper_bound
to 110 112 766 768 O
screening 113 122 769 778 O

FEV1 0 4 779 783 B-clinical_variable
< 5 6 784 785 O
85 6 8 785 787 B-upper_bound
% 8 9 787 788 I-upper_bound
and 10 13 789 792 O
> 14 15 793 794 O
35 15 17 794 796 B-lower_bound
% 17 18 796 797 I-lower_bound
at 19 21 798 800 O
screening 22 31 801 810 O
and 32 35 811 814 O
baseline 36 44 815 823 O

For 0 3 824 827 O
subjects 4 12 828 836 O
on 13 15 837 839 O
cycled 16 22 840 846 B-treatment
therapy 23 30 847 854 I-treatment
, 30 31 854 855 O
at 32 34 856 858 O
least 35 40 859 864 O
2 41 42 865 866 B-lower_bound
cycles 43 49 867 873 O
of 50 52 874 876 O
drug 53 57 877 881 O
need 58 62 882 886 O
to 63 65 887 889 O
have 66 70 890 894 O
been 71 75 895 899 O
completed 76 85 900 909 O
prior 86 91 910 915 O
to 92 94 916 918 O
baseline 95 103 919 927 O

For 0 3 928 931 O
women 4 9 932 937 B-gender
of 10 12 938 940 O
child 13 18 941 946 O
bearing 19 26 947 954 O
potential 27 36 955 964 O

GGT 0 3 965 968 B-clinical_variable
> 4 5 969 970 O
3 6 7 971 972 B-lower_bound
x 8 9 973 974 I-lower_bound
ULN 10 13 975 978 I-lower_bound

Hemoglobin 0 10 979 989 B-clinical_variable
< 11 12 990 991 O
10 13 15 992 994 B-upper_bound
g 16 17 995 996 I-upper_bound
/ 17 18 996 997 I-upper_bound
dl 18 20 997 999 I-upper_bound

Initiation 0 10 1000 1010 O
of 11 13 1011 1013 O
any 14 17 1014 1017 O
new 18 21 1018 1021 B-treatment
chronic 22 29 1022 1029 I-treatment
therapy 30 37 1030 1037 I-treatment
( 38 39 1038 1039 O
e.g. 39 43 1039 1043 O
, 43 44 1043 1044 O
ibuprofen 45 54 1045 1054 B-treatment
, 54 55 1054 1055 O
Pulmozyme 56 65 1056 1065 B-treatment
® 65 66 1065 1066 O
, 66 67 1066 1067 O
hypertonic 68 78 1068 1078 B-treatment
saline 79 85 1079 1085 I-treatment
, 85 86 1085 1086 O
azithromycin 87 99 1087 1099 B-treatment
, 99 100 1099 1100 O
TOBI 101 105 1101 1105 B-treatment
® 105 106 1105 1106 O
, 106 107 1106 1107 O
Cayston 108 115 1108 1115 B-treatment
® 115 116 1115 1116 O
) 116 117 1116 1117 O
within 118 124 1118 1124 O
4 125 126 1125 1126 B-upper_bound
weeks 127 132 1127 1132 I-upper_bound
prior 133 138 1133 1138 I-upper_bound
to 139 141 1139 1141 O
screening 142 151 1142 1151 O

Intravenous 0 11 1152 1163 B-treatment
or 12 14 1164 1166 I-treatment
oral 15 19 1167 1171 I-treatment
steroids 20 28 1172 1180 I-treatment
in 29 31 1181 1183 O
the 32 35 1184 1187 O
14 36 38 1188 1190 B-upper_bound
days 39 43 1191 1195 I-upper_bound
prior 44 49 1196 1201 I-upper_bound
to 50 52 1202 1204 O
screening 53 62 1205 1214 O

Male 0 4 1215 1219 B-gender

Methemoglobn 0 12 1220 1232 B-clinical_variable
> 13 14 1233 1234 O
3 14 15 1234 1235 B-lower_bound
% 15 16 1235 1236 I-lower_bound

Non 0 3 1237 1240 O
- 3 4 1240 1241 O
smoker 4 10 1241 1247 O
for 11 14 1248 1251 O
at 15 17 1252 1254 O
least 18 23 1255 1260 O
6 24 25 1261 1262 B-upper_bound
months 26 32 1263 1269 I-upper_bound
prior 33 38 1270 1275 I-upper_bound
to 39 41 1276 1278 O
screening 42 51 1279 1288 O
and 52 55 1289 1292 O
agrees 56 62 1293 1299 O
not 63 66 1300 1303 O
to 67 69 1304 1306 O
smoke 70 75 1307 1312 O
during 76 82 1313 1319 O
the 83 86 1320 1323 O
study 87 92 1324 1329 O

Ongoing 0 7 1330 1337 O
chronic 8 15 1338 1345 O
inhaled 16 23 1346 1353 B-treatment
antibiotic 24 34 1354 1364 I-treatment
therapy 35 42 1365 1372 I-treatment
for 43 46 1373 1376 O
at 47 49 1377 1379 O
least 50 55 1380 1385 O
3 56 57 1386 1387 B-lower_bound
months 58 64 1388 1394 I-lower_bound
prior 65 70 1395 1400 I-lower_bound
to 71 73 1401 1403 O
( 74 75 1404 1405 O
screening 75 84 1405 1414 O
or 85 87 1415 1417 O
baseline 88 96 1418 1426 O
) 96 97 1426 1427 O

Platelet 0 8 1428 1436 B-clinical_variable
count 9 14 1437 1442 I-clinical_variable
< 15 16 1443 1444 O
100,000 16 23 1444 1451 B-upper_bound
/ 23 24 1451 1452 I-upper_bound
mm3 24 27 1452 1455 I-upper_bound

Prothrombin 0 11 1456 1467 B-clinical_variable
time 12 16 1468 1472 I-clinical_variable
international 17 30 1473 1486 I-clinical_variable
ratio 31 36 1487 1492 I-clinical_variable
( 37 38 1493 1494 I-clinical_variable
INR 38 41 1494 1497 I-clinical_variable
) 41 42 1497 1498 I-clinical_variable
> 43 44 1499 1500 O
1.5 45 48 1501 1504 B-lower_bound

SaO2 0 4 1505 1509 B-clinical_variable
> 5 6 1510 1511 O
90 6 8 1511 1513 B-lower_bound
% 8 9 1513 1514 I-lower_bound
on 10 12 1515 1517 O
room 13 17 1518 1522 O
air 18 21 1523 1526 O
at 22 24 1527 1529 O
screening 25 34 1530 1539 O
and 35 38 1540 1543 O
baseline 39 47 1544 1552 O

Significant 0 11 1553 1564 O
hemoptysis 12 22 1565 1575 B-chronic_disease
within 23 29 1576 1582 O
30 30 32 1583 1585 B-upper_bound
days 33 37 1586 1590 I-upper_bound
prior 38 43 1591 1596 I-upper_bound
to 44 46 1597 1599 O
screening 47 56 1600 1609 O
( 57 58 1610 1611 O
≥5 58 60 1611 1613 O
mL 61 63 1614 1616 I-lower_bound
of 64 66 1617 1619 O
blood 67 72 1620 1625 O
in 73 75 1626 1628 O
one 76 79 1629 1632 O
coughing 80 88 1633 1641 O
episode 89 96 1642 1649 O
or 97 99 1650 1652 O
> 100 101 1653 1654 O
30 101 103 1654 1656 B-lower_bound
mL 104 106 1657 1659 I-lower_bound
of 107 109 1660 1662 O
blood 110 115 1663 1668 O
in 116 118 1669 1671 O
a 119 120 1672 1673 O
24 121 123 1674 1676 B-upper_bound
hour 124 128 1677 1681 I-upper_bound
period 129 135 1682 1688 O
) 135 136 1688 1689 O

Two 0 3 1690 1693 O
respiratory 4 15 1694 1705 B-chronic_disease
tract 16 21 1706 1711 I-chronic_disease
cultures 22 30 1712 1720 O
negative 31 39 1721 1729 O
for 40 43 1730 1733 O
NTM 44 47 1734 1737 O
in 48 50 1738 1740 O
the 51 54 1741 1744 O
last 55 59 1745 1749 O
year 60 64 1750 1754 O
, 64 65 1754 1755 O
with 66 70 1756 1760 O
no 71 73 1761 1763 O
subsequent 74 84 1764 1774 O
positive 85 93 1775 1783 O
cultures 94 102 1784 1792 O

Use 0 3 1793 1796 O
of 4 6 1797 1799 O
a 7 8 1800 1801 O
nitric 9 15 1802 1808 B-treatment
oxide 16 21 1809 1814 I-treatment
donor 22 27 1815 1820 I-treatment
agent 28 33 1821 1826 I-treatment
such 34 38 1827 1831 O
as 39 41 1832 1834 O
nitroglycerin 42 55 1835 1848 B-treatment
or 56 58 1849 1851 O
drugs 59 64 1852 1857 O
known 65 70 1858 1863 O
to 71 73 1864 1866 O
increase 74 82 1867 1875 O
methemoglobin 83 96 1876 1889 O
such 97 101 1890 1894 O
as 102 104 1895 1897 O
lidocaine 105 114 1898 1907 B-treatment
, 114 115 1907 1908 O
prilocaine 116 126 1909 1919 B-treatment
, 126 127 1919 1920 O
benzocaine 128 138 1921 1931 B-treatment
or 139 141 1932 1934 O
dapsone 142 149 1935 1942 B-treatment
at 150 152 1943 1945 O
screening 153 162 1946 1955 O

Use 0 3 1956 1959 O
of 4 6 1960 1962 O
an 7 9 1963 1965 O
investigational 10 25 1966 1981 B-treatment
drug 26 30 1982 1986 I-treatment
within 31 37 1987 1993 O
30 38 40 1994 1996 B-upper_bound
days 41 45 1997 2001 I-upper_bound
prior 46 51 2002 2007 I-upper_bound
to 52 54 2008 2010 O
screening 55 64 2011 2020 O

Use 0 3 2021 2024 O
of 4 6 2025 2027 O
antibiotics 7 18 2028 2039 B-treatment
[ 19 20 2040 2041 O
oral 20 24 2041 2045 B-treatment
, 24 25 2045 2046 O
intravenous 26 37 2047 2058 B-treatment
( 38 39 2059 2060 I-treatment
iv 39 41 2060 2062 I-treatment
) 41 42 2062 2063 I-treatment
, 42 43 2063 2064 O
and/or 44 50 2065 2071 O
inhaled 51 58 2072 2079 B-treatment
] 58 59 2079 2080 O
for 60 63 2081 2084 O
acute 64 69 2085 2090 B-chronic_disease
respiratory 70 81 2091 2102 I-chronic_disease
symptoms 82 90 2103 2111 I-chronic_disease
within 91 97 2112 2118 O
2 98 99 2119 2120 B-upper_bound
weeks 100 105 2121 2126 I-upper_bound
prior 106 111 2127 2132 I-upper_bound
to 112 114 2133 2135 O
baseline 115 123 2136 2144 O

Use 0 3 2145 2148 O
of 4 6 2149 2151 O
supplemental 7 19 2152 2164 O
oxygen 20 26 2165 2171 O
( 27 28 2172 2173 O
daytime 28 35 2173 2180 O
or 36 38 2181 2183 O
nocturnal 39 48 2184 2193 O
) 48 49 2193 2194 O
in 50 52 2195 2197 O
the 53 56 2198 2201 O
7 57 58 2202 2203 B-upper_bound
days 59 63 2204 2208 I-upper_bound
prior 64 69 2209 2214 I-upper_bound
to 70 72 2215 2217 O
screening 73 82 2218 2227 O

Willing 0 7 2228 2235 O
and 8 11 2236 2239 O
able 12 16 2240 2244 O
to 17 19 2245 2247 O
comply 20 26 2248 2254 O
with 27 31 2255 2259 O
the 32 35 2260 2263 O
treatment 36 45 2264 2273 B-treatment
schedule 46 54 2274 2282 O
and 55 58 2283 2286 O
procedures 59 69 2287 2297 O

Willing 0 7 2298 2305 O
to 8 10 2306 2308 O
be 11 13 2309 2311 O
off 14 17 2312 2315 O
of 18 20 2316 2318 O
inhaled 21 28 2319 2326 B-treatment
antibiotic 29 39 2327 2337 I-treatment
therapy 40 47 2338 2345 I-treatment
from 48 52 2346 2350 O
Day 53 56 2351 2354 O
1 57 58 2355 2356 O
to 59 61 2357 2359 O
Day 62 65 2360 2363 O
15 66 68 2364 2366 O

a 0 1 2367 2368 O
genotype 2 10 2369 2377 O
with 11 15 2378 2382 O
two 16 19 2383 2386 O
identifiable 20 32 2387 2399 O
mutations 33 42 2400 2409 O
consistent 43 53 2410 2420 O
with 54 58 2421 2425 O
CF 59 61 2426 2428 B-chronic_disease

female 0 6 2429 2435 B-gender
subjects 7 15 2436 2444 I-gender

one 0 3 2445 2448 O
of 4 6 2449 2451 O
these 7 12 2452 2457 O
two 13 16 2458 2461 O
cultures 17 25 2462 2470 O
has 26 29 2471 2474 O
to 30 32 2475 2477 O
have 33 37 2478 2482 O
been 38 42 2483 2487 O
obtained 43 51 2488 2496 O
within 52 58 2497 2503 O
the 59 62 2504 2507 O
last 63 67 2508 2512 B-upper_bound
6 68 69 2513 2514 I-upper_bound
months 70 76 2515 2521 I-upper_bound

positive 0 8 2522 2530 B-pregnancy
pregnancy 9 18 2531 2540 I-pregnancy
test 19 23 2541 2545 O
at 24 26 2546 2548 O
screening 27 36 2549 2558 O

positive 0 8 2559 2567 O
sweat 9 14 2568 2573 B-clinical_variable
chloride 15 23 2574 2582 I-clinical_variable
60 24 26 2583 2585 B-upper_bound
mEq 27 30 2586 2589 I-upper_bound
/ 30 31 2589 2590 I-upper_bound
liter 31 36 2590 2595 I-upper_bound
( 37 38 2596 2597 O
by 38 40 2597 2599 O
pilocarpine 41 52 2600 2611 O
iontophoresis 53 66 2612 2625 O
) 66 67 2625 2626 O

these 0 5 2627 2632 O
2 6 7 2633 2634 B-upper_bound
respiratory 8 19 2635 2646 O
cultures 20 28 2647 2655 O
must 29 33 2656 2660 O
be 34 36 2661 2663 O
separated 37 46 2664 2673 O
by 47 49 2674 2676 O
at 50 52 2677 2679 O
least 53 58 2680 2685 O
3 59 60 2686 2687 B-lower_bound
months 61 67 2688 2694 I-lower_bound

unwilling 0 9 2695 2704 B-contraception_consent
to 10 12 2705 2707 I-contraception_consent
practice 13 21 2708 2716 I-contraception_consent
a 22 23 2717 2718 I-contraception_consent
medically 24 33 2719 2728 I-contraception_consent
acceptable 34 44 2729 2739 I-contraception_consent
form 45 49 2740 2744 I-contraception_consent
of 50 52 2745 2747 I-contraception_consent
contraception 53 66 2748 2761 I-contraception_consent
from 67 71 2762 2766 O
screening 72 81 2767 2776 O
to 82 84 2777 2779 O
Day 85 88 2780 2783 O
36 89 91 2784 2786 O
( 92 93 2787 2788 O
acceptable 93 103 2788 2798 B-contraception_consent
forms 104 109 2799 2804 I-contraception_consent
of 110 112 2805 2807 I-contraception_consent
contraception 113 126 2808 2821 I-contraception_consent
: 126 127 2821 2822 O
abstinence 128 138 2823 2833 B-contraception_consent
, 138 139 2833 2834 O
hormonal 140 148 2835 2843 B-contraception_consent
birth 149 154 2844 2849 I-contraception_consent
control 155 162 2850 2857 I-contraception_consent
, 162 163 2857 2858 O
intrauterine 164 176 2859 2871 B-contraception_consent
device 177 183 2872 2878 I-contraception_consent
, 183 184 2878 2879 O
or 185 187 2880 2882 O
barrier 188 195 2883 2890 B-contraception_consent
method 196 202 2891 2897 I-contraception_consent
plus 203 207 2898 2902 I-contraception_consent
a 208 209 2903 2904 I-contraception_consent
spermicidal 210 221 2905 2916 I-contraception_consent
agent 222 227 2917 2922 I-contraception_consent
) 227 228 2922 2923 O

≥18 0 3 2924 2927 O
years 4 9 2928 2933 I-lower_bound

